Relationship between patients' age, bone marrow karyotype, and outcome of induction therapy in acute myelogenous leukemia
✍ Scribed by Dr. Ph. Bernard; F. Lacombe; J. Reiffers; B. David; G. Marit; M. J. Bourdeau; A. Broustet
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 351 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
Bone marrow karyotypes were performed in 88 cases of adult acute myelogenous leukemia (AML) at diagnosis and classified NN (normal), AA (abnormal), and AN (mixture of normal and abnormal metaphases). A clear relationship was found between karyotype and complete remission (CR) rate: 58% CR in (NN + AN) cases; 14% CR in AA cases (P < ,009). This relationship was even stronger when only patients under 60 years of age were studied. Considering failures of induction treatment, no relationship was found between the NN/AN/AA classification and a drug resistance. In patients over 60, the worse prognosis could be explained by an inferior ability to tolerate intensive treatment.